Unlike PSA, PCA3 expression remains constant during prostatic hyperplasia and prostatitis, thereby making it more sensitive than PSA for PCa detection and it has therefore been suggested that the PCA3 score be used as an exclusion tool [95,96]. The gene discussed is KLK3; the disease is urogenital neoplasm.